🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Acutaas Chemicals Limited ACUTAAS NIFTY_SMALLNSEINFRA

Basic Materials · Specialty Chemicals · India
https://www.acutaas.com
Company Profile ↓
₹3,510.00
+209.78% 1Y
Mkt Cap₹28,735.99 Cr
P/E80.67
P/B17.31
Div. Yield0.04%
52W High₹3,694.80
52W Low₹1,133.05
Book Value₹202.03
EPS (TTM)₹43.51

Company Overview

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 21.5%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 16.5%.

Consistent Profit Growth

Net profit has compounded at 30.2% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 24.3% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 26.6%.

Recent Developments

  • Mar 2026 Revenue of ₹1,339.00 Cr (+33.9% YoY); net profit ₹356.00 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +33.9%, earnings +124.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR 24.3%, profit CAGR 30.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:24.34%
1 Year:33.90%

Compounded Profit Growth

5 Years:30.18%
1 Year:124.30%

Stock Price Performance

1 Year:+209.78%
6 Months:+108.28%
3 Months:+49.97%
1 Month:+13.35%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 93% of range
₹1,133.05 ₹3,694.80
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)59.69 · Neutral
Price Performance
1M+13.35%
3M+49.97%
6M+108.28%
1Y+209.78%
Valuation vs Sector

P/E of 80.67 is above the sector median of 27.45 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 21.5%.
  • Excellent profit margin of 26.6%.
  • Compounding revenue at 24.3% over 5 years.
  • Profit CAGR of 30.2% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 80.7.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
80.67
Industry PE
27.45
Forward P/E
51.35
PEG Ratio
-
Book Value
₹202.03
Price to Book
17.31
P/S
21.37
EV/EBITDA
59.30
Dividend Yield
0.04%

Growth (CAGR)

Revenue 5Y
24.34%
Profit 5Y
30.18%
Revenue (YoY)
33.90%
Earnings (YoY)
124.30%

Profitability & Returns

ROCE
16.51%
ROE
21.52%
ROA
17.94%
Profit Margin
26.59%
Op Margin
33.16%
Gross Margin
30.34%
EPS (Latest Qtr)
₹16.09
EPS (TTM)
₹43.51

Balance Sheet & Liquidity

Debt/Equity
2.18
Quick Ratio
3.02
Current Ratio
3.91
Debt
₹36.00 Cr
Total Assets
₹1,549.26 Cr
Current Assets
₹791.64 Cr
Working Capital
₹589.39 Cr

Ownership

Promoter Holding
38.34%
Chg in Prom Hold
5.68%
FII / Inst Holding
27.14%
Chg in FII Hold
0.07%

Financial Snapshot

Enterprise Value
₹28,735.99 Cr
Total Revenue (TTM)
₹1,339.00 Cr
EBITDA
₹480.00 Cr
Free Cash Flow
₹-36.00 Cr
Operating Cash Flow
₹292.00 Cr
Shares Outstanding
₹8.19 Cr
Gross Margin
30.34%
Payout Ratio
4.29%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ACUTAAS Acutaas Chemicals Limited NIFTY_SMALLNSEINFRA 3,510.00 80.67 ₹28,735.99 Cr 0.04% 16.51% 21.52% 24.34% 30.18%
2 ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA 11,659.00 56.84 ₹3.44 L Cr 0.66% 11.90% 10.66% 12.40% 17.26%
3 JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA 1,244.70 86.92 ₹3.04 L Cr 0.57% 18.75% 22.30% 3.61% 75.28%
4 ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA 2,675.50 59.31 ₹2.57 L Cr 1.03% 24.41% 20.24% 1.10% 1.75%
5 TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA 187.67 21.70 ₹2.34 L Cr 2.09% 11.32% 10.56% -1.59% 7.21%
6 HINDZINC Hindustan Zinc Limited NSEINFRA 532.50 16.26 ₹2.25 L Cr 3.91% 61.97% 61.13% 5.61% 9.58%
7 HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA 963.55 16.01 ₹2.17 L Cr 0.52% 9.42% 9.80% 7.10% 9.87%
8 GRASIM Grasim Industries Limited NIFTY50NSEINFRA 3,133.10 56.45 ₹2.13 L Cr 0.31% 4.00% 4.80% 14.63% -10.06%
9 VAML Vedanta Aluminium Metal Limited NSEINFRA 452.95 inf ₹1.77 L Cr 0.00% 41.97% 49.39% - -46.32%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 186.00 Cr154.00 Cr172.00 Cr166.00 Cr225.00 Cr177.00 Cr246.73 Cr274.99 Cr301.57 Cr207.24 Cr306.00 Cr393.18 Cr433.00 Cr
Cost of Revenue ------139.55 Cr147.81 Cr204.04 Cr96.89 Cr-169.17 Cr-
Gross Profit ------107.18 Cr127.18 Cr97.54 Cr110.35 Cr-224.01 Cr-
Operating Expenses 146.00 Cr120.00 Cr148.00 Cr140.00 Cr182.00 Cr147.00 Cr65.07 Cr64.83 Cr19.88 Cr67.57 Cr211.00 Cr83.18 Cr249.00 Cr
Operating Income 38.00 Cr30.00 Cr21.00 Cr23.00 Cr38.00 Cr24.00 Cr42.11 Cr62.35 Cr77.66 Cr42.78 Cr87.00 Cr140.83 Cr174.00 Cr
EBITDA 41.00 Cr34.00 Cr25.00 Cr27.00 Cr43.00 Cr30.00 Cr57.37 Cr70.34 Cr90.74 Cr66.84 Cr95.00 Cr155.35 Cr184.00 Cr
Interest Expense 1.00 Cr1.00 Cr1.00 Cr3.00 Cr2.00 Cr4.00 Cr50.27 L68.61 L60.32 L63.85 L1.00 Cr86.12 L1.00 Cr
Pretax Income 37.00 Cr31.00 Cr-10.00 Cr24.00 Cr37.00 Cr20.00 Cr50.04 Cr63.33 Cr82.83 Cr58.08 Cr96.00 Cr144.67 Cr184.00 Cr
Tax Provision 9.62 Cr8.68 Cr-7.10 Cr6.00 Cr11.47 Cr5.20 Cr12.47 Cr17.89 Cr20.12 Cr14.07 Cr24.00 Cr38.45 Cr49.68 Cr
Net Income 27.00 Cr22.00 Cr-17.00 Cr18.00 Cr26.00 Cr15.00 Cr37.57 Cr44.95 Cr62.48 Cr44.29 Cr72.00 Cr107.96 Cr134.00 Cr
Diluted EPS 3.732.71-2.552.273.411.714.695.68-5.418.8213.1016.09

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 160.00 Cr188.00 Cr239.00 Cr240.00 Cr341.00 Cr520.13 Cr613.06 Cr713.01 Cr999.97 Cr1,339.00 Cr
Cost of Revenue -----272.84 Cr373.68 Cr454.80 Cr593.73 Cr-
Gross Profit -----247.30 Cr239.38 Cr258.21 Cr406.23 Cr-
Operating Expenses 137.00 Cr157.00 Cr196.00 Cr198.00 Cr260.00 Cr152.20 Cr128.37 Cr145.78 Cr200.78 Cr859.00 Cr
Operating Income 22.00 Cr29.00 Cr39.00 Cr38.00 Cr76.00 Cr95.10 Cr111.01 Cr112.43 Cr205.45 Cr444.00 Cr
EBITDA 23.00 Cr31.00 Cr42.00 Cr42.00 Cr80.00 Cr107.94 Cr126.93 Cr103.90 Cr249.00 Cr480.00 Cr
Interest Expense 3.00 Cr3.00 Cr5.00 Cr6.00 Cr6.00 Cr6.41 Cr2.41 Cr5.94 Cr6.22 Cr3.00 Cr
Pretax Income 19.00 Cr28.00 Cr35.00 Cr35.00 Cr72.00 Cr91.45 Cr112.17 Cr81.90 Cr216.16 Cr483.00 Cr
Tax Provision 6.65 Cr9.80 Cr11.90 Cr7.35 Cr18.00 Cr19.50 Cr28.88 Cr33.19 Cr55.75 Cr125.58 Cr
Net Income 12.00 Cr18.00 Cr23.00 Cr27.00 Cr54.00 Cr71.95 Cr83.29 Cr42.77 Cr158.71 Cr356.00 Cr
Diluted EPS 40.1761.6711.1013.088.5710.5211.435.8319.8143.51

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 109.00 Cr155.00 Cr213.00 Cr232.00 Cr413.00 Cr658.88 Cr766.94 Cr1,095.90 Cr1,549.26 Cr1,984.00 Cr
Current Assets -----429.15 Cr457.13 Cr493.30 Cr791.64 Cr-
Cash & Equivalents -----10.30 Cr30.53 Cr29.70 Cr185.22 Cr-
Inventory -----112.17 Cr119.17 Cr156.73 Cr179.94 Cr-
Receivables -----163.70 Cr230.26 Cr206.35 Cr290.49 Cr-
Total Liabilities -----136.61 Cr172.98 Cr413.15 Cr229.18 Cr-
Current Liabilities -----129.32 Cr162.85 Cr285.17 Cr202.25 Cr-
Long Term Debt -----58.81 L62.59 L113.64 Cr0-
Total Debt 27.00 Cr44.00 Cr54.00 Cr59.00 Cr137.00 Cr84.41 L3.60 Cr216.65 Cr12.94 Cr36.00 Cr
Total Equity 39.00 Cr58.00 Cr82.00 Cr111.00 Cr167.00 Cr522.27 Cr593.96 Cr674.00 Cr1,309.63 Cr1,654.00 Cr
Shares Outstanding -----7.29 Cr7.29 Cr7.38 Cr8.19 Cr-

Cash Flows (Annual)

Figures in INR.

Metric Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 29.00 Cr8.00 Cr15.00 Cr27.00 Cr28.00 Cr-11.93 Cr65.53 Cr125.17 Cr118.34 Cr292.00 Cr
Investing Cash Flow -19.00 Cr-25.00 Cr-21.00 Cr-24.00 Cr-101.00 Cr-120.72 Cr-33.04 Cr-365.39 Cr-223.94 Cr-266.00 Cr
Financing Cash Flow -7.00 Cr15.00 Cr6.00 Cr072.00 Cr140.26 Cr-12.25 Cr239.36 Cr261.12 Cr4.00 Cr
Capital Expenditure -19.00 Cr-24.00 Cr-22.00 Cr-21.00 Cr-105.00 Cr-33.76 Cr-96.40 Cr-314.68 Cr-194.64 Cr-328.00 Cr
Free Cash Flow 10.00 Cr-16.00 Cr-7.00 Cr6.00 Cr-77.00 Cr-45.69 Cr-30.87 Cr-189.51 Cr-76.30 Cr-36.00 Cr
Net Change in Cash 3.00 Cr-2.00 Cr-03.00 Cr-1.00 Cr7.61 Cr20.24 Cr-86.02 L155.52 Cr30.00 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----47.5%39.0%36.2%40.6%-
Operating Margin % 13.8%15.4%16.3%15.8%22.3%18.3%18.1%15.8%20.5%33.2%
Net Margin % 7.5%9.6%9.6%11.2%15.8%13.8%13.6%6.0%15.9%26.6%
ROE % 30.8%31.0%28.0%24.3%32.3%13.8%14.0%6.3%12.1%21.5%
ROCE % -----18.0%18.4%13.9%15.3%-

Shareholding Pattern

Insiders
38.34%
Institutions
27.14%
Public Float
44.01%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ACUTAAS

Google News ue, 30 Jun 2026

Why This Pharma Chemicals Company Is Betting On Three Megatrends At Once - NDTV Profit

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxOYVNNNkVyZUdLcnR5U05UbF8tUmxDMmppcUVLT3ZiaGxJcG5acjVXU1RwRXhHVmJyQ3dWLVloc192UnNsRXhsTjFUczRTaDFERkMxRE9wNk0xV1lZWFdjaEdRN2NmTFZNdDQ2QWg3c1J4a1g1ZjZzQWtsUGNmazlQQlB4MmVSaVY1Q3FEUl…

Google News ue, 14 Jul 2026

Acutaas Chemicals - 12 stocks held by 100+ MFs in June surged up to 105% in just over 6 months - The Economic Times

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxOSFF2MTZIaXJ1aGNQcy1rUE82Q2xDd3NOa2FSLTZsYURZSllOZ2g5T01QYVVnbGVMekMyU251eldHdS1VU09tT3h1Q0F4MFk5QTRYREVrNzN3aFM3QVREazRWWjV3bzFiVU55TW1OTEVLZk1kVEl0dGZiVWhQNTd4dnBoeDZWVk1nWm0wUj…

Google News Wed, 28 Jan 2026

ACUTAAS: Robust revenue and profit growth, share split, and major JV investment marked the period - TradingView

<a href="https://news.google.com/rss/articles/CBMiiAJBVV95cUxQOWQyWXh4MUNNU2tCdUVEM3dSOS0xT0tQSlhVWF9TazdTRlI4X0F3YlV1a0N4a1lPSENud185MEdMNzRoSnhvMTdCQjE2XzNPODViUXNFb0VsWWhBb3B1N0pEMVdVS2NyN1pwWjlmQlpGRXdjY2gtdE0weWNIdTBSYnNpc0FuaV90VjNJZX…

Google News Mon, 06 Apr 2026

Acutaas Chemicals: A compelling business at an unforgiving price - Value Research

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPVWpjbU11aW0zSC03T041VnRNYUc2N0ZQRWhUZkhSRVhyRVNTU2p4TEtreWVfZDQxVFRHUjBRYUk5bHBQZjR5R3BvRzVZVS1ncGh3b1pTZ21ZLUhXNVlKajh3Nk0tNHVQNlpCZEkwakFfeFlsa1F1RGZ4UkVINEp1M0sxV0dmQUprMEthbV…

Google News hu, 09 Jul 2026

Volumes soar at Acutaas Chemicals Ltd counter - Business Standard

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQZ3RDQWxQS2NsbXE2ZHRfNWYzNFI2NER2aEtuRnFEX2NIeFdSYTVGcE1DNUVlS1c3dUR6a0p1Nmo4S1VGOUU2UjI3cXM5VTdaYjhGemEzZGZnaHFYX3BWWXdzUVIza1JPUEpULXJYOEdMVzhOM1lydzMyU0tGaDJwYmREUkRHRXpIeWlZbV…

Google News Mon, 18 May 2026

Acutaas Chemicals: The specialty chemicals story the market is re-rating fast - The Indian Express

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPV2tIU2s2UVFUN1RwbmRsR1JjN2RnOTBOdXZza1ZtZ2FoakJkVUpvWTdKNXR2X2pTaklZaXdWV0NacWNETmhlUWJjbkV6Xy1ES3VQaTRPekxQRUhKc21GUWF6a1pzc0Z3dW82QXFMYmdHRTBRN0doSXVYWFR1TzRUUEJzZlhFWlFHaDlQMk…

ACUTAAS — Frequently Asked Questions

What is the current share price of Acutaas Chemicals Limited (ACUTAAS)?

As of 2026-07-15 09:52 IST, Acutaas Chemicals Limited (ACUTAAS) trades at ₹3,510.00 on NSE. Its 52-week range is ₹1,133.05 to ₹3,694.80.

What is the market capitalisation of ACUTAAS?

Acutaas Chemicals Limited (ACUTAAS) has a market capitalisation of ₹28,735.99 Cr on NSE.

What is the P/E ratio of ACUTAAS?

ACUTAAS trades at a trailing price-to-earnings (P/E) ratio of 80.67. The industry average P/E is 27.45. Its price-to-book (P/B) ratio is 17.31.

Does ACUTAAS pay a dividend?

Acutaas Chemicals Limited (ACUTAAS) currently offers a dividend yield of 0.04%.

What is the return on equity (ROE) of ACUTAAS?

ACUTAAS has a return on equity (ROE) of 21.52%. Its return on capital employed (ROCE) is 16.51%.

Is ACUTAAS a good stock to buy?

This page provides a data-driven analysis of Acutaas Chemicals Limited (ACUTAAS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space